← Insider buys
TERN

Terns Pharmaceuticals, Inc. · Healthcare

Chief Medical Officer Emil Kuriakose sold $50K of Terns Pharmaceuticals, Inc.

Sold$49,693
$52.75Price
942Shares
−1%Stake

What TERN did after the filing

Filed Apr 2Copier in Apr 6
The stock from Mon, Apr 6 open, $52.73
+0.4%
S&P 500, same days
+11.5%

23 of 30 trading days so far, to the May 7 close.

Traded Wed, Apr 1. Filed Thu, Apr 2, 6:15 PM ET, after the close. Returns use the Apr 6 open and the May 7 close. Not investment advice.